News
-
-
PRESS RELEASE
Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant
New data shows Sarclisa induction therapy improves progression-free survival in transplant-eligible newly diagnosed multiple myeloma patients. GMMG-HD7 study results are promising for Sarclisa as part of frontline treatment -
-
-
-
PRESS RELEASE
Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A
NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data showing high-sustained factor levels with once-weekly dosing in children with severe hemophilia A, effective bleed protection, and no inhibitor development to factor VIII -
-
PRESS RELEASE
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM
Positive phase 3 data of Dupixent in children aged 1-11 with eosinophilic esophagitis published in NEJM highlights significant histologic remission achieved and sustained improvements, potentially changing standard of care -
-
